Vita Coco (COCO) CCO sells 8,561 shares, retains 67,130
Rhea-AI Filing Summary
Vita Coco Company, Inc. Chief Commercial Officer Charles van Es reported an open-market sale of 8,561 shares of common stock at $70.0000 per share. After this transaction, he directly holds 67,130 shares of common stock.
The sale was effected under a Rule 10b5-1 trading plan, indicating it was pre-arranged. Van Es also continues to hold multiple non-qualified stock options to buy common stock, with exercise prices between $10.1780 and $33.3600 and expiration dates from 2030 through 2035.
Positive
- None.
Negative
- None.
Insights
Routine insider sale under a 10b5-1 plan, with substantial equity position retained.
Chief Commercial Officer Charles van Es sold 8,561 shares of Vita Coco Company, Inc. common stock at $70.0000 per share in an open-market transaction. The filing notes the sale was executed pursuant to a Rule 10b5-1 trading plan, meaning it was pre-scheduled rather than opportunistic.
Following the sale, van Es continues to directly hold 67,130 common shares, plus several non-qualified stock option grants with exercise prices from $10.1780 to $33.3600 expiring between 2030 and 2035. This mix of retained stock and long-dated options suggests the transaction is part of ongoing liquidity and diversification rather than a full-scale exit.
From an investor perspective, a single 10b5-1 sale of this size is typically viewed as a routine compensation-related event. The more informative elements are the remaining direct share ownership and the sizeable unexercised option grants, which keep the executive’s incentives aligned with future share performance.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 8,561 | $70.00 | $599K |
| holding | Non-Qualified Stock Option (Right to Buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (Right to Buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (Right to Buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (Right to Buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (Right to Buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (Right to Buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (Right to Buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (Right to Buy) | -- | -- | -- |
Footnotes (1)
- The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan. The stock option is fully vested and currently exercisable. The stock option vests in four equal annual installments beginning on November 27, 2022. The stock option vests in three equal annual installments beginning on August 15, 2025. The stock option is eligible to vest if certain performance conditions are met by the target date for the applicable performance condition(s) and expire if the performance conditions are not met by the final target date. The performance conditions applicable were timely satisfied, resulting in vesting of the option as to 14,025 shares on February 20, 2026. The stock options vest in four annual equal installments beginning on March 10, 2024. The stock option vests in four equal annual installments beginning on March 4, 2025. The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.
Key Figures
Key Terms
Rule 10b5-1 trading plan financial
Non-Qualified Stock Option (Right to Buy) financial
performance conditions financial
vests in four equal annual installments financial
fully vested and currently exercisable financial
